AstraZeneca's revenue from top product Crestor 2006-2023
This statistic describes AstraZeneca's revenue from one of its top products, Crestor, from 2006 to 2023. In 2023, the revenue amounted to 1.1 billion U.S. dollars. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.